The Luxembourg-based healthcare investment vehicle Auna said it is reconsidering a US IPO.

Auna previously filed initial papers for a stock market listing with the US Securities and Exchange Commission in 2020, but then withdrew its application in 2022. At the time, it had planned to raise $100m.

“The Company is contemplating consummating the proposed initial public offering sometime in 2024, but both the offering itself and the timing thereof are subject to market conditions, other considerations, and the completion of the SEC’s review process,” it on 25 October. “The underlying decision to raise equity capital in the international capital markets is a part of Auna’s broader strategy to strengthen its capital base, extend its debt maturities and continue its expansion in Spanish Speaking Latin America.”

Auna was founded in 2008 and its operational management is based in Lima. It runs cancer care and medical care centres in Peru, and healthcare facilities in Colombia and Mexico, which the company said collectively employ 14,000 staff.

For the 6 months ending 30 June 2023, it posted total revenue of $1.8bn (up year-on-year from $1.1bn), gross profit of $688m (compared to $383m) and a segment operating profit of $281m (up from $3.8m posted in the January-June 2022 period).

Last month, the credit agency Fitch reaffirmed its B rating on Auna’s bonds, and earlier this year S&P upgraded Auna’s credit score to B. Those ratings are middle-of-the-pack.